Machine learning‐based gene alteration prediction model for primary lung cancer using cytologic images. Issue 10 (20th June 2022)

• Record Type: Journal Article
• Authors: Ishii, Shuhei; Takamatsu, Manabu; Ninomiya, Hironori; Inamura, Kentaro; Horai, Takeshi; Iyoda, Akira; Honma, Naoko; Hoshi, Rira; Sugiyama, Yuko; Yanagitani, Noriko; Mun, Mingyon; Abe, Hitoshi; Mikami, Tetuo; Takeuchi, Kengo
• Is Part Of: Cancer cytopathology. Volume 130:Issue 10(2022)
• Page Start: 812
• Page End: 823
• Publication Date: 2022-06-20
• Subjects: ALK -- artificial intelligence -- cytology -- EGFR -- KRAS -- lung cancer -- prediction; Cancer -- Cytopathology -- Periodicals; Pathology, Cellular -- Periodicals; Cytology -- Technique -- Periodicals; 611.01815
• DOI: 10.1002/cncy.22609
• Languages: English
• ISSNs: 1934-662X

Abstract

Abstract: Background: Understanding the gene alteration status of primary lung cancers is important for determining treatment strategies, but gene testing is both time‐consuming and costly, limiting its application in clinical practice. Here, potential therapeutic targets were selected by predicting gene alterations in cytologic specimens before conventional gene testing. Methods: This was a retrospective study to develop a cytologic image–based gene alteration prediction model for primary lung cancer. Photomicroscopic images of cytology samples were collected and image patches were generated for analyses. Cancer‐positive ( n = 106) and cancer‐negative ( n = 32) samples were used to develop a neural network model for selecting cancer‐positive images. Cancer‐positive cases were randomly assigned to training ( n = 77) and validation ( n = 26) data sets. Another neural network model was developed to classify cancer images of the training data set into 4 groups: anaplastic lymphoma kinase (ALK)‐fusion, epidermal growth factor receptor (EGFR), or Kirsten rat sarcoma viral oncogene homologue (KRAS) mutated groups, and other (None group), and images of the validation data set were classified. A decision algorithm to predict gene alteration for cases with 3 probability ranks was developed. Results: The accuracy and precision for selecting cancer‐positive patches were 0.945 and 0.991, respectively. Predictive accuracy for the EGFR and KRAS groups in the validation data set was ~0.95, whereas that for the ALK and None groups was ~0.75 and ~ 0.80, respectively. Gene status was correctly predicted in the probability rank A cases. The model extracted characteristic conventional cytologic findings in images and a novel specific feature was discovered for the EGFR group. Conclusions: A gene alteration prediction model for lung cancers by machine learning based on cytologic images was successfully developed. Abstract : Supervised machine learning of photomicroscopic images can be used to predict the gene alteration status of primary lung adenocarcinomas from cytologic specimens. A machine learning model extracted a novel cytologic feature that predicted an epidermal growth factor receptor mutation with high specificity.